Uyen Dinh, PhD and I were delighted to be asked to contribute to a special edition of Frontiers in Immunology on “Advancing Treg Cell Therapy”. We outline the key nonclinical considerations for opening an IND for Treg therapies.
Uyen Dinh, PhD and I were delighted to be asked to contribute to a special edition of Frontiers in Immunology on “Advancing Treg Cell Therapy”. We outline the key nonclinical considerations for opening an IND for Treg therapies.
Related Articles